Dermatological toxicities, such as hair loss and skin changes, are common adverse effects of cancer treatments, often causing body image disturbances, psychological distress, and stigma. These side effects can lead to dose reductions or treatment discontinuation, negatively impacting clinical outcomes. Pharmacists are well positioned to support patients by optimizing treatment outcomes and managing side effects, with studies supporting the role of pharmaceutical interventions in community pharmacy settings. Despite the recognized psychosocial impact of dermatological toxicities, few psychoeducational interventions exist. This project aims to develop a pharmaceutical care protocol for the prevention and management of dermatological toxicities in cancer patients, and to identify psychosocial key components that promote a positive body image in patients experiencing these side effects. The combined outcomes will support the integration of pharmaceutical care into oncology, fostering multidisciplinary, evidencebased interventions to improve treatment adherence, psychosocial well-being, and quality of life in cancer patients.